The facts that they have already signed contract with few sites in Germany and NL, Revenue has already generated not like other biotech that just in a pre-commercialisation phrase, I am confident that the list will just keep growing.CE approval is also highly likely in EU, so AUS will eventually follow, Risk of success if very low, IMO
IMR Price at posting:
$1.31 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)